Cardiometabolic Health: Beyond the scale, semaglutide is known to improve markers of heart health, including blood pressure, cholesterol levels, and blood sugar control
Baseline Risk Identification Many metabolic conditions are asymptomatic in early stages: Prediabetes and insulin resistance Non-alcoholic fatty liver disease (NAFLD) Chronic kidney disease Thyroid dysfunction Without baseline labs, these conditions may go unnoticedyet they directly influence how a patient responds to GLP-1 therapy
Designer vagina surgery has become a popular option among women seeking to address aesthetic concerns or discomfort While PCOS symptoms can become evident any time after puberty, most women are diagnosed when trying to become pregnant in their 20s and 30s
After you stop taking a GLP-1 RA, it will take some time for the last dose to be cleared from your system
Serious adverse effects requiring monitoring include: Hypoglycemia : While GLP-1 receptor agonists have low intrinsic hypoglycemia risk due to glucose-dependent mechanisms, risk increases with concomitant insulin or sulfonylurea use
